177 related articles for article (PubMed ID: 9266499)
21. Occurrence of porphyromonas gingivalis and its antibacterial susceptibility to metronidazole and tetracycline in patients with chronic periodontitis.
Gamboa F; Acosta A; García DA; Velosa J; Araya N; Ledergerber R
Acta Odontol Latinoam; 2014; 27(3):137-44. PubMed ID: 25560693
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an in vitro study.
Eick S; Pfister W
J Periodontol; 2004 Oct; 75(10):1327-34. PubMed ID: 15562909
[TBL] [Abstract][Full Text] [Related]
23. Comparative gene expression analysis of Porphyromonas gingivalis ATCC 33277 in planktonic and biofilms states.
Romero-Lastra P; Sánchez MC; Ribeiro-Vidal H; Llama-Palacios A; Figuero E; Herrera D; Sanz M
PLoS One; 2017; 12(4):e0174669. PubMed ID: 28369099
[TBL] [Abstract][Full Text] [Related]
24. The anthraquinone rhein exhibits synergistic antibacterial activity in association with metronidazole or natural compounds and attenuates virulence gene expression in Porphyromonas gingivalis.
Azelmat J; Larente JF; Grenier D
Arch Oral Biol; 2015 Feb; 60(2):342-6. PubMed ID: 25463909
[TBL] [Abstract][Full Text] [Related]
25. Effects of a high-molecular-weight cranberry fraction on growth, biofilm formation and adherence of Porphyromonas gingivalis.
Labrecque J; Bodet C; Chandad F; Grenier D
J Antimicrob Chemother; 2006 Aug; 58(2):439-43. PubMed ID: 16735419
[TBL] [Abstract][Full Text] [Related]
26. Invasion of Porphyromonas gingivalis into human gingival fibroblasts in vitro.
Amornchat C; Rassameemasmaung S; Sripairojthikoon W; Swasdison S
J Int Acad Periodontol; 2003 Oct; 5(4):98-105. PubMed ID: 14604058
[TBL] [Abstract][Full Text] [Related]
27. Structure, viability and bacterial kinetics of an in vitro biofilm model using six bacteria from the subgingival microbiota.
Sánchez MC; Llama-Palacios A; Blanc V; León R; Herrera D; Sanz M
J Periodontal Res; 2011 Apr; 46(2):252-60. PubMed ID: 21261622
[TBL] [Abstract][Full Text] [Related]
28. The effects of antibiotics on in vitro biofilm model of periodontal disease.
Tamura A; Ara T; Imamura Y; Fujii T; Wang PL
Eur J Med Res; 2008 Sep; 13(9):439-45. PubMed ID: 18948236
[TBL] [Abstract][Full Text] [Related]
29. Capsaicin inhibits Porphyromonas gingivalis growth, biofilm formation, gingivomucosal inflammatory cytokine secretion, and in vitro osteoclastogenesis.
Zhou Y; Guan X; Zhu W; Liu Z; Wang X; Yu H; Wang H
Eur J Clin Microbiol Infect Dis; 2014 Feb; 33(2):211-9. PubMed ID: 23955115
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Emdogain® antimicrobial effectiveness against biofilms containing the keystone pathogen Porphyromonas gingivalis.
Lasserre J; Toma S; Dos Santos-Gonçalvez AM; Leprince J; Leloup G; Brecx M
New Microbiol; 2018 Jan; 41(1):73-76. PubMed ID: 29313865
[TBL] [Abstract][Full Text] [Related]
31. Development of resistance to metronidazole and minocycline in vitro.
Larsen T; Fiehn NE
J Clin Periodontol; 1997 Apr; 24(4):254-9. PubMed ID: 9144048
[TBL] [Abstract][Full Text] [Related]
32. High in vitro antibacterial activity of Pac-525 against Porphyromonas gingivalis biofilms cultured on titanium.
Li JY; Wang XJ; Wang LN; Ying XX; Ren X; Liu HY; Xu L; Ma GW
Biomed Res Int; 2015; 2015():909870. PubMed ID: 25710035
[TBL] [Abstract][Full Text] [Related]
33. Gene expression of Porphyromonas gingivalis ATCC 33277 when growing in an in vitro multispecies biofilm.
Romero-Lastra P; Sánchez MC; Llama-Palacios A; Figuero E; Herrera D; Sanz M
PLoS One; 2019; 14(8):e0221234. PubMed ID: 31437202
[TBL] [Abstract][Full Text] [Related]
34. Metronidazole susceptibility testing of anaerobic bacteria associated with periodontal disease.
Poulet PP; Duffaut D; Lodter JP
J Clin Periodontol; 1999 Apr; 26(4):261-3. PubMed ID: 10223399
[TBL] [Abstract][Full Text] [Related]
35. Inhibitory effect of gels loaded with a low concentration of antibiotics against biofilm formation by Enterococcus faecalis and Porphyromonas gingivalis.
A Algarni A; H Yassen G; L Gregory R
J Oral Sci; 2015 Sep; 57(3):213-8. PubMed ID: 26369485
[TBL] [Abstract][Full Text] [Related]
36. BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis-Streptococcus gordonii biofilms.
Mahmoud MY; Demuth DR; Steinbach-Rankins JM
J Nanobiotechnology; 2018 Sep; 16(1):69. PubMed ID: 30219060
[TBL] [Abstract][Full Text] [Related]
37. Antibacterial TAP-mimic electrospun polymer scaffold: effects on P. gingivalis-infected dentin biofilm.
Albuquerque MT; Evans JD; Gregory RL; Valera MC; Bottino MC
Clin Oral Investig; 2016 Mar; 20(2):387-93. PubMed ID: 26319981
[TBL] [Abstract][Full Text] [Related]
38. Effects of sub-minimal inhibitory concentrations of antibiotics on the morphology and surface hydrophobicity of periodontopathic anaerobes.
Lee SY; Lee SY
Anaerobe; 2019 Feb; 55():107-111. PubMed ID: 30423437
[TBL] [Abstract][Full Text] [Related]
39. Disinfect Porphyromonas gingivalis Biofilm on Titanium Surface with Combined Application of Chlorhexidine and Antimicrobial Photodynamic Therapy.
Cai Z; Li Y; Wang Y; Chen S; Jiang S; Ge H; Lei L; Huang X
Photochem Photobiol; 2019 May; 95(3):839-845. PubMed ID: 30481378
[TBL] [Abstract][Full Text] [Related]
40. Bismuth drugs tackle Porphyromonas gingivalis and attune cytokine response in human cells.
Cheng T; Lai YT; Wang C; Wang Y; Jiang N; Li H; Sun H; Jin L
Metallomics; 2019 Jul; 11(7):1207-1218. PubMed ID: 31179464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
